Globus Medical (GMED) Tops Q4 EPS by 5c

Globus Medical (NYSE: GMED) reported Q4 EPS of $0.30, $0.05 better than the analyst estimate of $0.25. Revenue for the quarter came in at $128.8 million versus the consensus estimate of $127.77 million.

For earnings history and earnings-related data on Globus Medical (GMED) click here.

You May Also Be Interested In

• Royal Caribbean to acquire 50% stake in Sandals Resorts for $3 billion
• Activist Jana Partners calls for Six Flags sale - WSJ
• KeyBanc Sees 'A Potential Catalyst for Earnings Growth and Value Creation' for Acadia Realty Trust (AKR)